HoldsUp

The Diary Of A CEO · 2026-07-02 · Steven Bartlett (host), Martin Picard

The Mitochondria Doctor: This Reverses Gray Hair, Makes You Feel Young Again & Fixes Disease!

67 research-tied claims examined: 2 contradicted 2 overstated 6 context 56 supported 1 unverified

2 Contradicted by research
1:04:43Martin Picardcontradictedhigh

Neuroimaging shows that some elderly individuals have full-blown Alzheimer's disease with zero brain protein deposits, while others have high amyloid plaque and tau tangle burdens with completely normal cognition.

"You can have people in their 60s and their 70s and their 80s, zero protein deposit in the brain. We can image this now pretty well with neuroimaging. You can have people zero protein deposit in the brain, and they have full-blown Alzheimer's and dementia. And you have the other extreme, people with loads of amyloid plaques and tau tangles, completely normal cognition." (said at 1:04:43)

The claim bundles two assertions with conflicting accuracy: 1. Dementia with 'zero protein deposits': Contradicted. Under current consensus criteria (such as the NIA-AA Research Framework), Alzheimer's disease is biologically defined by amyloid-β and tau pathology. While older adults can present with dementia or cognitive impairment without amyloid or tau deposits, these syndromes represent non-Alzheimer's etiologies (e.g., vascular dementia, frontotemporal lobar degeneration, or LATE/TDP-43), not 'full-blown Alzheimer's disease'. 2. High plaque/tangle burden with normal cognition: Supported. Extensive neuroimaging and cohort data (e.g., the Mayo Clinic Study of Aging) demonstrate that substantial amyloid plaque and tau tangle deposition occurs in cognitively unimpaired older individuals (preclinical Alzheimer's disease), representing cognitive resilience or early-stage pathological accumulation prior to clinical symptom onset. Following the evaluation rule to grade based on the least accurate bundled assertion, the overall verdict is contradicted.

1:49:14Martin Picardcontradictedhigh

GDF15 is expressed by peripheral organs but not by the brain, whereas its receptor (GFRAL) is located exclusively in the brainstem area postrema.

"and that protein can be made by any organ in the body except one. The brain... Where is the receptor? Right?... Only in one organ in the body... Yeah, so in the brainstem. The The brainstem is where kind of the the basic survival systems of the body are and there's a region in the brainstem called the area postrema." (said at 1:49:14)

The speaker bundles two distinct assertions: 1) that GDF15 is produced by every organ except the brain, and 2) that its receptor (GFRAL) is located exclusively in the brainstem area postrema. The receptor localization claim is supported: multiple landmark studies demonstrate that GFRAL expression is restricted almost exclusively to neurons in the area postrema and nucleus of the solitary tract (AP/NTS) in the caudal brainstem. However, the claim that the brain cannot or does not produce GDF15 is contradicted: GDF15 is actively expressed within the central nervous system (by neurons, microglia, and astrocytes), particularly in response to aging, neuroinflammation, cellular stress, and neurodegenerative diseases. Following grading rules for bundled assertions, the overall claim receives the verdict of its least accurate component.

2 Overstated
1:16:12Steven Bartlett (host)overstatedlow

Studies of indigenous hunter-gatherer populations like the Hadza in Tanzania and rural agrarian groups like the Yoruba find that Alzheimer's and vascular dementia are exceptionally rare.

"when researchers study indigenous groups such as the Hadza hunter-gatherer tribe in Tanzania or rural agrarian populations like the Yoruba, they find that Alzheimer's and vascular dementia are exceptionally rare." (said at 1:16:12)

The claim partially reflects published literature but misattributes findings to the Hadza. The landmark Indianapolis-Ibadan Dementia Project demonstrated that Yoruba living in Ibadan, Nigeria had significantly lower prevalence (1.41% vs. 6.24%) and annual incidence (1.15% vs. 2.52%) of Alzheimer's disease compared to African Americans in Indianapolis (PMID: 7573588, PMID: 11176911). However, no formal epidemiological studies have quantified Alzheimer's or vascular dementia prevalence in the Hadza hunter-gatherers of Tanzania; the speaker likely conflated Hadza metabolic/activity research with recent dementia research on indigenous subsistence populations such as the Bolivian Tsimane and Moseten, who were found to have exceptionally low dementia prevalence (~1.2%, PMID: 35262289).

2:22:00Martin Picardoverstatedmoderate

Studies show that in individuals with chronic fatigue syndrome, inflammatory markers and energetic stress signals skyrocket after exercise, leading to post-exertional malaise.

"And and there's some studies that show increased inflammation. So, those signals of energy resistance, increased energy friction in the body, uh go up after exercise in a normal person. In these people with chronic fatigue, it seems like they can skyrocket and then that leads to this uh post-exertional malaise." (said at 2:22:00)

While individuals with ME/CFS exhibit altered metabolic and physiological responses to exercise—including heightened oxidative stress, impaired antioxidant responses, and altered immune gene expression—systematic reviews of exercise-challenge studies consistently show that circulating pro- and anti-inflammatory cytokines do not surge or 'skyrocket' after exercise compared to healthy controls, nor do circulating cytokines reliably explain post-exertional malaise.

6 Needs context
0:00:50Martin Picardneeds contextvery low

Stress hormones increase human energy expenditure by 16%.

"And we found that the stress hormone increased energy expenditure by 16%." (said at 0:00:50)

The speaker appears to refer to experimental laboratory findings from their research group examining cellular bioenergetics under stress hormone exposure. In primary human cell culture models (such as fibroblasts), exposure to stress mediators (catecholamines or glucocorticoids) induces hypermetabolic state shifts and raises cellular energy expenditure and oxidative phosphorylation (e.g., PMID 42465469, PMID 37423094). However, these measurements reflect in vitro cellular ATP turnover and oxygen consumption in cultured human cells rather than a demonstrated, fixed 16% elevation in whole-body human resting metabolic rate.

0:08:37Martin Picardneeds contextmoderate

There are on average approximately 1,000 mitochondria per human cell.

"There's on average 1,000 mitochondria per cell." (said at 0:08:37)

A count of roughly 1,000 to 2,000 mitochondria per cell is a standard biological estimate commonly cited for typical nucleated human somatic cells (such as hepatocytes). However, mitochondrial abundance varies by orders of magnitude across cell types based on metabolic and energetic demands: mature erythrocytes (which constitute the vast majority of human cells by count) contain zero mitochondria, lymphocytes contain a few hundred, cardiomyocytes and neurons contain thousands to millions, and mature oocytes contain several hundred thousand.

0:16:56Martin Picardneeds contextmoderate

Mitochondria originated roughly 1.5 billion years ago via endosymbiosis between two distinct types of bacteria.

"So, the story is about 1.5 billion years ago that there was two different types of bacteria. One type was able to use oxygen to transform energy, right? So, it could fuel along oxygen and and other food substrates. The other type could not." (said at 0:16:56)

The speaker accurately describes the broad timeline (~1.5–2 billion years ago) and mechanism of mitochondrial origin via endosymbiosis involving an oxygen-utilizing prokaryote (an alphaproteobacterial ancestor capable of aerobic respiration). However, the claim describes the event as occurring between 'two different types of bacteria'. Modern phylogenomics and evolutionary biology demonstrate that eukaryogenesis occurred between two distinct domains of life: an alphaproteobacterial endosymbiont and an archaeal host cell closely related to Asgard archaea, rather than two bacterial lineages.

0:21:40Martin Picardneeds contexthigh

Cancer cells exhibit the Warburg effect by opting for fermentation and avoiding mitochondrial respiration even in the presence of oxygen.

"It's called the Warburg effect. And the Warburg effect is when a cell, in the presence of oxygen, right? If it wanted, it could use oxygen, flow electrons through mitochondria, and transform energy, and and live a nice social life, uh like every cell in in this social collective does in the body. Uh what cancer cells do is they say, "I'm not going to use my mitochondria, even if there's oxygen, even if my mitochondria can respire."" (said at 0:21:40)

The speaker accurately defines the core observation of the Warburg effect (aerobic glycolysis): cancer cells preferentially ferment glucose to lactate even when oxygen is abundant. However, describing this as cancer cells completely 'opting out' of or refusing to use their mitochondria is inaccurate. Modern cancer biology has established that most cancer cells retain functional mitochondria and actively utilize mitochondrial respiration and oxidative phosphorylation alongside glycolysis to meet biosynthetic and bioenergetic demands.

1:57:21Martin Picardneeds contextmoderate

Direct oral ingestion of pure NAD+ has poor cellular bioavailability compared to oral precursor supplementation or intravenous NAD+ infusion.

"If you eat NAD directly, it doesn't the bioavailability, it's called, it doesn't get into, you know, your cells very well. You can inject, infuse IV, intravenously, uh NAD+ directly, and then that gets to your cells better." (said at 1:57:21)

The speaker claims that direct oral ingestion of NAD+ has poor cellular bioavailability compared to oral precursors or intravenous NAD+ infusion. It is well established biochemically and clinically that intact NAD+ is an impermeable, large charged dinucleotide that is rapidly hydrolyzed by extracellular and digestive enzymes (such as CD38 and CD73) into precursors (nicotinamide mononucleotide, nicotinamide riboside, or nicotinamide) prior to intracellular uptake, which is why smaller oral precursors (NR, NMN, nicotinamide) are standardly used. However, claiming that IV NAD+ directly enters cells better than oral ingestion overlooks the fact that IV NAD+ is also rapidly degraded by extracellular ectoenzymes rather than crossing intact cellular membranes directly, although both oral precursors and IV infusions do elevate NAD+ metabolome pools.

0:13:12Martin Picardneeds contextmoderate

During a heart attack, the loss of oxygen delivery prevents mitochondrial electrons from flowing to oxygen, causing electron backflow that produces oxidative stress and tissue damage.

"The source of that pain really is blood flow can no longer bring oxygen to mitochondria in the heart... And then all of a sudden there's no more oxygen. So the electrons have nowhere to go. That feels terrible. The electrons can't flow, so they start to backflow. That is what causes oxidative stress. That's why the heart gets damaged during a heart attack." (said at 0:13:12)

The speaker accurately outlines the concept of mitochondrial electron transport stalling and reverse electron transport (RET / electron backflow) driving reactive oxygen species (ROS) generation and myocardial injury during a heart attack. However, a key physiological nuance is missing: during profound ischemia (complete lack of oxygen), reactive oxygen species cannot form because oxygen is required as the substrate to accept electrons and create superoxide. Instead, ischemia causes a buildup of reducing equivalents and succinate; the massive burst of ROS via reverse electron transport at Complex I predominantly occurs upon reoxygenation/reperfusion when oxygen re-enters the tissue.

56 Supported by research
0:00:00Martin Picardsupportedlow

Graying of human hair is biologically reversible.

"This is incontrovertible evidence that graying of hair is reversible and it can be pretty fast." (said at 0:00:00)

A landmark 2021 study by Rosenberg et al. (PMID: 34155974) developed high-resolution hair pigmentation pattern (HPP) profiling along individual human hair shafts. The researchers demonstrated quantitative, natural repigmentation (reversal of greying) across sexes, ethnicities, ages, and body sites. The transitions from grey to pigmented occurred rapidly over days to weeks and were found to correlate with reductions in psychological stress, confirming that hair greying is biologically reversible under certain conditions.

0:00:06Martin Picardsupportedmoderate

Marijuana consumption from 6 months prior can be detected in human hair.

"Like, for example, if you had marijuana 6 months ago, it's going to be in your hair." (said at 0:00:06)

Hair analysis incorporates drug metabolites (such as 11-nor-9-carboxy-THC or THC-COOH) into the growing hair shaft at an average rate of approximately 1 cm per month. Consequently, analyzing a 6-centimeter hair segment or hair collected months after drug cessation allows for the retrospective detection of cannabis consumption from 6 months prior, limited primarily by the length of the hair sample available.

0:01:14Steven Bartlett (host)supportedlow

Post-mortem studies of human brains show that individuals with a greater sense of purpose have more efficient mitochondria.

"Well, I read that studies on brains of dead people have found that those with the greatest sense of purpose have more efficient mitochondria." (said at 0:01:14)

A 2024 study published in PNAS (linking antemortem psychosocial data to postmortem dorsolateral prefrontal cortex tissue from older adults) found that higher psychological well-being and purpose in life were associated with higher levels of oxidative phosphorylation (OxPhos) machinery and Complex I proteins in the brain, whereas negative affect was associated with reduced OxPhos protein abundance. Because the findings derive from an observational, postmortem cohort study, the certainty of evidence is low, but the claim accurately reflects the published research findings.

0:14:51Martin Picardsupportedmoderate

There are approximately 5 trillion nucleated cells containing mitochondria in the human body.

"And there's about 5 trillion cells in your body uh that have a nucleus and that have these beautiful mitochondria." (said at 0:14:51)

Quantitative biological estimates of the cellular composition of the reference human body show a total of approximately 30 trillion (3.0 × 10^13) to 37 trillion (3.7 × 10^13) cells. Of these, roughly 84% to 90% are enucleated, non-mitochondrial cells of the hematopoietic lineage (primarily ~25-26 trillion mature red blood cells/erythrocytes and ~1.5 trillion platelets). Subtracting these leaves approximately 4 to 5 trillion nucleated cells that contain mitochondria (such as white blood cells, endothelial cells, muscle cells, adipocytes, and glial cells), directly matching the speaker's claim.

0:24:44Martin Picardsupportedmoderate

Diabetes is a major risk factor for developing cancer.

"Diabetes is a major risk factor for developing cancer." (said at 0:24:44)

Large-scale epidemiological studies, meta-analyses, and umbrella reviews demonstrate that diabetes (particularly type 2 diabetes mellitus) is a significant risk factor for the development of multiple site-specific cancers, including endometrial, pancreatic, colorectal, liver/biliary, and breast cancers. Observational associations and Mendelian randomization studies consistently show increased cancer incidence in individuals with type 2 diabetes.

0:28:50Martin Picardsupportedhigh

Mitochondria trigger apoptosis and possess a veto mechanism over cell survival or cell death.

"So, mitochondria have a veto on cell life or death, and cancer somehow is able to kind of get away from that." (said at 0:28:50)

The speaker's statement accurately describes established cellular biology. Mitochondria serve as central arbiters of intrinsic apoptosis via mitochondrial outer membrane permeabilization (MOMP), widely described as the 'point of no return' determining cell survival versus programmed cell death. MOMP allows the release of pro-apoptotic proteins like cytochrome c to activate downstream caspases. Furthermore, cancer cells commonly evade this mitochondrial 'veto' control by upregulating anti-apoptotic proteins (such as BCL-2 family members) or suppressing pro-apoptotic factors to prevent MOMP and resist apoptosis.

  • supports: Mitochondria as therapeutic targets for cancer chemotherapy. (Oncogene 2006) · cited 333x in the literature
    "Mitochondria are vital for cellular bioenergetics and play a central role in determining the point-of-no-return of the apoptotic process. As a consequence, mitochondria exert a dual function in carcinogenesis. Cancer-associated changes in cellular metabolism (the Warburg effect) influence mitochondrial function, and the invalidation of apoptosis is linked to an inhibition of mitochondrial outer membrane permeabilization (MOMP)." (abstract, passage verified)
    pubmedfull study (doi)
  • supports: Mitochondrial regulation of cell death. (Cold Spring Harbor perspectives in biology 2013) · cited 536x in the literature
    "Mitochondria regulate caspase activation and cell death through an event termed mitochondrial outer membrane permeabilization (MOMP); this leads to the release of various mitochondrial intermembrane space proteins that activate caspases, resulting in apoptosis. MOMP is often considered a point of no return because it typically leads to cell death, even in the absence of caspase activity." (abstract, passage verified)
    pubmedfull study (doi)
  • supports: Mechanisms of mitochondrial cell death. (Biochemical Society transactions 2021) · cited 97x in the literature
    "Mitochondrial outer membrane permeabilization (MOMP), allowing the release of intermembrane space proteins like cytochrome c, is considered a point of no return in apoptosis. MOMP is controlled by the proteins of the B-cell lymphoma 2 (BCL-2) family, including pro-and anti-apoptotic members, whose balance determines the decision between cell death and survival." (abstract, passage verified)
    pubmedfull study (doi)
0:08:27Martin Picardsupportedhigh

Mitochondria releasing heat during the process of electron transport is the primary source of human body warmth.

"The reason the body is warm is because the mitochondria, as they transform and flow electrons like a little energetic circuit, they release heat. So the the source of heat, right, that makes us warm, you shake someone's hand, you feel their warmth, you're feeling the warmth from their mitochondria." (said at 0:08:27)

The speaker's statement accurately reflects established bioenergetic principles. Human endothermy (body warmth) is primarily generated as a byproduct of cellular metabolism, predominantly driven by mitochondrial oxidative phosphorylation. As electrons flow through the mitochondrial electron transport chain, a substantial fraction of the free energy is dissipated directly as heat (due to thermodynamic overpotential and basal/regulated proton leak across the inner mitochondrial membrane), with the remainder converted to ATP that also eventually dissipates as heat upon utilization.

  • supports: Mitochondrial proton and electron leaks. (Essays in biochemistry 2010) · cited 835x in the literature
    "The basal leak is unregulated, and a major proportion can be attributed to mitochondrial anion carriers, whereas the proton leak through the lipid bilayer appears to be minor. The basal proton leak is cell-type specific and correlates with metabolic rate. The inducible leak through the ANT (adenine nucleotide translocase) and UCPs (uncoupling proteins) can be activated by fatty acids, superoxide or lipid peroxidation products. The physiological role of inducible leak through UCP1 in mammalian brown adipose tissue is heat production" (abstract, passage verified)
    pubmedfull study (doi)
  • supports: Enzymatic oxygen reduction dominates overpotential-driven thermogenesis in mitochondria. (Chemical science 2026)
    "we develop a chemistry-based framework that models intracellular heat production as the dissipation of Gibbs free energy through enzymatic overpotentials in the mitochondrial electron transport chain, analogous to Joule heat in fuel cells. By treating each respiratory complex as a resistive kinetic step and calibrating the model with experimentally measured electrochemical parameters, we estimate that 45-71% of respiration energy is dissipated as heat." (abstract, results, passage verified)
    pubmedfull study (doi)
0:26:10Martin Picardsupportedhigh

Cigarette smoke contains chemical carcinogens that directly damage the genome and cause genetic mutations.

"It's clear that in cigarette smoke, there are carcinogens. They're molecules that can damage the genome and cause mutations." (said at 0:26:10)

Extensive mechanistic and genomic evidence confirms that cigarette smoke contains numerous chemical carcinogens (such as polycyclic aromatic hydrocarbons like benzo[a]pyrene and tobacco-specific nitrosamines) that covalently bind DNA, induce bulky adducts and oxidative lesions, and lead to characteristic somatic mutational signatures and driver mutations across the genome.

0:26:32Martin Picardsupportedhigh

Obesity is established in scientific research as being linked to an increased risk of cancer.

"And uh the the science behind, you know, connecting metabolism and cancer shows that obesity and uh high blood glucose and diabetes especially, which causes very high, you know, excursion I have very high spikes in in blood glucose, those things are damaging to our cells." (said at 0:26:32)

Extensive epidemiological research, including umbrella reviews of prospective observational studies and meta-analyses, firmly establishes that obesity and metabolic dysfunction increase the risk of at least 13 to 14 distinct cancer types (including endometrial, colorectal, kidney, liver, gastric, esophageal, and postmenopausal breast cancers), demonstrating consistent dose-response relationships.

0:31:39Martin Picardsupportedmoderate

Hair graying is naturally reversible, and individual human hairs can lose pigmentation and subsequently regain color.

"what we discovered is that hair graying is reversible... we found the hairs that uh, you know, head hair, beard hair, pubic hairs that showed the signature. The hair was dark and then it became white or the hair was white and it became dark again. So we had physical evidence from like multiple people that showed white hairs can go back to being dark." (said at 0:31:39)

A landmark study by Rosenberg et al. (2021) from Martin Picard's group developed high-resolution quantitative mapping of hair pigmentation patterns (HPPs) along individual hair shafts. They demonstrated that individual human hairs (from scalp, beard, and pubic regions across diverse donors) can undergo natural transitions from dark to white and subsequently undergo repigmentation from white back to dark, confirming that hair graying can naturally reverse.

0:34:13Martin Picardsupportedmoderate

Proteomic analysis reveals that unpigmented white hair segments contain a higher abundance of mitochondrial proteins compared to dark pigmented segments.

"when we looked at the hair and we analyzed the the composition, the molecular composition, that's what scientists do. You can take a hair like this, snip the pieces, the white segment, the dark segment... We found that the white hairs have more mitochondria. And there was an upregulation of the body that the hair follicle where the hair was becoming old wasn't kind of letting go of things." (said at 0:34:13)

Proteomic analysis of human hair shafts with pigmentation transitions (comparing dark and white segments of the same hairs) demonstrated that unpigmented white/grey segments showed a marked upregulation of proteins related to mitochondria, energy metabolism, and antioxidant defenses compared to pigmented segments.

0:37:14Martin Picardsupportedvery low

In a cell culture model, exposure to cortisol increased cellular energy expenditure by 60%.

"You put You put cells in a dish. You give them the equivalent of cortisol. How much energy is going to cost for these cells to prepare?... We found that the stress hormone increased energy expenditure, at the cost of life, by 60%." (said at 0:37:14)

In a 2023 study by Martin Picard's group investigating cellular allostatic load across the lifespan of primary human fibroblasts, chronic glucocorticoid exposure (a synthetic glucocorticoid model equivalent to cortisol exposure) increased cellular energy expenditure by ~60% and accelerated markers of cellular aging (DNA methylation age, telomere shortening, and reduced lifespan). Because this evidence comes directly from an in vitro cell culture model, certainty is graded as very low.

0:38:44Martin Picardsupportedlow

A completely white hair shaft can regain dark pigmentation in as little as about one week.

"This is incontrovertible evidence that graying of hair is reversible and it can be pretty pretty fast. Like this transition here is just a few weeks. This is about 1 week. Right? So, this white hair, completely white, regained color in just about a week." (said at 0:38:44)

A 2021 study by Rosenberg et al. (PMID 34155974) developed high-resolution quantitative hair pigmentation pattern (HPP) profiling along individual human hair shafts. By mapping pigmentation changes relative to known human hair growth rates (~1 cm/month or ~0.3-0.4 mm/day), the researchers quantitatively demonstrated rapid transitions in which completely white hair shafts regained dark pigmentation over short intervals of days to weeks (including transitions occurring within approximately 3 to 7 days). Because this evidence is derived from high-resolution observational single-hair tracking and small cohort profiling, certainty is graded as low.

0:46:48Martin Picardsupportedmoderate

Transitioning from a sedentary lifestyle to endurance exercise training can double skeletal muscle mitochondrial content.

"That's what happens if you go from being a sedentary couch potato, right? To training for a marathon. You can double the amount of mitochondria you have in your muscles." (said at 0:46:48)

Transitioning from a sedentary baseline to rigorous endurance exercise training (such as marathon training) markedly stimulates mitochondrial biogenesis in skeletal muscle. Landmark and subsequent physiological studies demonstrate that endurance training induces increases in both the size and number of muscle mitochondria, resulting in up to a twofold (100%) increase in mitochondrial respiratory proteins, cytochrome c content, and key oxidative enzyme activities, alongside substantial increases (typically 40% to 100%) in overall mitochondrial volume density and protein content.

  • supports: Adaptation of skeletal muscle to endurance exercise. (Medicine and science in sports 1975) · cited 190x in the literature
    "These increases in mitochondrial enzyme activity appear to be due to an increase in enzyme protein as evidenced by a doubling of the concentration of cytochrome c and a 60% increase in the protein content of the mitochondrial fraction skeletal muscle. Electronmicroscopic studies suggest that increases in both the size and number of mitochondria are responsible for the increase in mitochondrial protein. An alteration in mitochondrial composition also occurs, with some mitochondrial enzymes increasing 2-fold, others increasing only 35% to 60%" (abstract, passage verified)
    pubmed
0:59:10Martin Picardsupportedhigh

Ingesting alcohol increases human whole-body energy expenditure during metabolic chamber testing.

"So, there's a cool study where they brought people in, they gave them a bunch of alcohol, they're, you know, effectively drunk, and then they measured how much energy are they burning. And you can do those kind of studies, we've we've done those studies in the lab. In a small room, you put a human being, and then you just measure how much energy does it cost for them to stay alive... And then you can ask them, 'Okay, now drink this alcohol.' And then you measure, you look minute by minute, they drink the alcohol, and then you start to see, 'Woo, it climbs up.'" (said at 0:59:10)

Human whole-room indirect calorimetry (respiration chamber) and ventilated hood studies confirm that acute ethanol ingestion elicits a marked thermogenic response, increasing whole-body energy expenditure. When ethanol is added to the diet or substituted isocalorically for other macronutrients, whole-body 24-hour energy expenditure increases significantly (by roughly 4% to 7%), corresponding to an ethanol-induced thermic effect of approximately 17% to 22.5% of the ingested ethanol energy.

0:59:30Martin Picardsupportedmoderate

In South American children exposed to high pathogen burdens due to poor sanitation, the energetic cost of immune defense against gut parasites and infections diverts energy away from physical growth.

"There's good data in uh South America. Children who are exposed to more pathogens, right? There's no sanitation, they walk barefoot, they they eat stuff, you know, that's not clean, then um they have more pathogens uh in their gut, right? There's there's more uh viruses, bacteria, and parasites. Uh it costs energy to fight those things off." (said at 0:59:30)

The speaker's claim directly reflects published findings from energetic and anthropological studies of indigenous Shuar children in Amazonian Ecuador. Studies led by Urlacher and colleagues demonstrated that children exposed to high pathogen burdens and poor sanitation experience elevated resting energy expenditure (~20% higher in association with immune activity) and clear energetic trade-offs between immune activation and physical growth, with children experiencing up to a 49% reduction in growth velocity during periods of elevated immune activity.

1:03:20Martin Picardsupportedhigh

Mitophagy is the cellular process of selectively degrading and recycling poorly functioning mitochondria.

"Old mitochondria that don't work too too well anymore, they get degraded. It's called mitophagy. Autophagy is self-eating. Mitophagy is self-eating of the mitochondria." (said at 1:03:20)

The speaker's definition of mitophagy as the cellular degradation of damaged, dysfunctional, or aged mitochondria via selective autophagy is fully established in cell biology.

1:06:04Martin Picardsupportedmoderate

In the early stages of Alzheimer's disease, affected brain regions show an increase in energy demand and hypermetabolism before progressing to hypometabolism as symptoms emerge.

"what we know happens energetically in the brain is that initially, in the early stages of Alzheimer's, there's kind of an increase in energy demand. And there there are specific brain regions that tend to be more affected in some people, not all not all people tend to have those protein deposits. Those regions start to burn more energy. This is early phase, right?... And then over time, those brain regions become hypometabolic, and then that's when you start to have symptoms." (said at 1:06:04)

Human neuroimaging and biomarker studies demonstrate a biphasic trajectory in early Alzheimer's disease (AD) pathogenesis. During preclinical or earliest stages of amyloid accumulation and mild cognitive impairment, affected or compensatory brain regions exhibit transient glucose hypermetabolism (linked to microglial neuroinflammation and/or compensatory neuronal hyperactivation), which subsequently transitions into progressive hypometabolism as neurodegeneration advances and overt clinical symptoms emerge.

1:09:37Martin Picardsupportedhigh

In dementia, brain glucose transport and metabolism face increased resistance and diminished energy utilization.

"when you look in the brain, it's burning less energy. But, it's also harder for glucose to get inside the brain... so there's yes, a loss of efficiency but an increased resistance, right? Or a decrease in conductance for energy, for glucose for example, to get inside the brain to be processed and and be used." (said at 1:09:37)

Extensive clinical imaging (such as FDG-PET), human post-mortem analyses, and animal models demonstrate that Alzheimer's disease and other forms of dementia are characterized by cerebral glucose hypometabolism, impaired blood-brain barrier transport, and brain insulin resistance. A systematic review of 43 human and rodent studies confirmed consistent reductions in key glucose transporters (GLUT1 at the blood-brain barrier/astrocytes and GLUT3 on neurons) in the cortex and hippocampus, leading to impaired glucose entry and utilization in the brain.

1:14:00Martin Picardsupportedmoderate

Recent research shows that ketones can cross into the brain and be metabolized more easily than glucose, leading to improvements in cognitive function.

"there's new data now showing that ketones can enter the brain and be metabolized more easily, and can even kind of improve cognition." (said at 1:14:00)

Dual-tracer PET imaging studies demonstrate that while cerebral glucose uptake and metabolism deteriorate in conditions like mild cognitive impairment (MCI) and Alzheimer's disease, ketone uptake and metabolism remain intact. Randomized interventional trials using ketogenic medium-chain triglycerides (kMCT) show that ketones readily cross the blood-brain barrier, bypass the brain glucose deficit, and correlate with improvements in specific cognitive domains such as memory, executive function, and processing speed.

1:14:30Martin Picardsupportedhigh

Ketones are produced by mitochondria in the liver, with a minor amount produced by the kidneys, and the biochemical pathway from ketones to mitochondrial metabolism involves fewer enzymes than that of glucose.

"The liver mitochondria is where ketones are made. If you eat fat, right? Avocados and oil and and meat and uh butter, and those fat molecules go in the liver, and then the mitochondria in the liver take those fat, transform them into ketones, and then put the ketones into the blood. The kidneys also do a little bit of this. And then the ketones go to the brain, and then they feed the mitochondria in the brain... And the path for a ketone to go from blood to mitochondria is much shorter in terms of number of enzymes, number of resistors, if you want to think about it energetically, than for glucose." (said at 1:14:30)

The speaker's statement accurately reflects standard biochemical physiology: 1) Ketone bodies are synthesized in the mitochondrial matrix of the liver from fatty acid oxidation; 2) The kidneys also carry out ketogenesis via renal proximal tubular HMGCS2; and 3) Ketolysis (the breakdown of ketones to acetyl-CoA for mitochondrial metabolism in target tissues like the brain) is a compact 3-enzyme pathway (BDH1, SCOT/OXCT1, and ACAT1/T2), which is significantly shorter than the multienzyme conversion of glucose to mitochondrial acetyl-CoA (the 10 sequential enzymes of glycolysis followed by the pyruvate dehydrogenase complex).

1:17:19Martin Picardsupportedmoderate

Most humans carry enough stored energy in fat and glycogen in muscles and the liver to survive for at least one month without food.

"most people have enough energy on board, right? In the form of fat, some glycogen in your muscles and in your liver to live at least a month." (said at 1:17:19)

Human metabolic physiology confirms that total endogenous fuel stores—predominantly adipose tissue triglycerides (tens of thousands to over 100,000 kcal in non-underweight individuals) along with initial glycogen reserves in the liver and skeletal muscle—provide sufficient energy to sustain life for at least 30 to 60 days of total caloric deprivation, provided adequate hydration is maintained. During extended fasting, the body transitions from initial glycogenolysis and gluconeogenesis to ketogenesis and lipolysis to spare protein and extend survival.

  • supports: Energy metabolism in feasting and fasting. (Advances in experimental medicine and biology 1979) · cited 115x in the literature
    "After about three days of starvation, the metabolic profile is set to conserve protein and to supply greater quantities of alternate fuels. In particular, free fatty acids and ketone bodies are utilized to maintain energy needs. The ability of the kidney to conserve ketone bodies prevents the loss of large quantities of these valuable fuels in the urine. This delicate interplay among liver, muscle, kidney, and adipose tissue maintains blood fuel homeostasis and allows humans to survive caloric deprivation for extended periods." (abstract, conclusions, passage verified)
    pubmedfull study (doi)
1:17:51Martin Picardsupportedvery low

The world record for fasting without food is over 300 days, held by an Irish man who lost 250 to 300 pounds.

"the record is world record for not eating is over 300 days. HOST: Wow. GUEST1: Irish man. Um and he lost I forget the exact numbers. 250 lbs, 300 lbs." (said at 1:17:51)

The claim refers to the famous case report of Angus Barbieri, published by Stewart and Fleming in 1973 (PMID: 4803438). The 27-year-old male fasted under medical supervision for 382 days (over 300 days), consuming only water, non-caloric fluids, and vitamin/mineral supplements. During the fast, his weight dropped from 456 lb (207 kg) to 180 lb (82 kg), a loss of 276 lb (fitting the stated 250–300 lbs). Although Barbieri was Scottish of Italian descent treated at Maryfield Hospital in Dundee, Scotland (rather than Irish), the substantive medical facts regarding duration and weight loss are accurate. As this is a single case report, the GRADE certainty is very low.

1:23:15Martin Picardsupportedmoderate

A high fever stimulates immune cells and weakens viruses during an infection.

"the high fever stimulates your immune cells and weakens the virus. So, it's a it's it's usually a good thing." (said at 1:23:15)

The claim is supported by immunological literature. Febrile temperatures stimulate both innate and adaptive immune cell responses (including enhanced lymphocyte trafficking, cytokine signaling, and immune activation) and impair the replication of many viral pathogens, representing an evolutionarily conserved host defense mechanism that confers survival benefit during infections.

1:21:45Steven Bartlett (host)supportedhigh

John Harvey Kellogg co-invented cornflakes and ran a sanitarium promoting a light, grain-based diet to cure indigestion.

"Enter Harvey Kellogg. Yes, that Kellogg's. He ran a famous health sanitarium and believed that a clean, light, grain-based diet would cure indigestion and improve overall health. He co-invented cornflakes" (said at 1:21:45)

Historical records confirm that Dr. John Harvey Kellogg served as superintendent of the Battle Creek Sanitarium, where he promoted a vegetarian, grain-based diet centered on digestive health. In his efforts to provide easily digestible foods to treat dyspepsia/indigestion and improve health, he co-invented flaked breakfast cereals, including Corn Flakes, which were later commercialized and mass-marketed by his brother Will Keith Kellogg.

1:24:10Martin Picardsupportedmoderate

The body's metabolic rate increases and burns more energy during an active infection and immune response.

"We know this is true from from, you know, good studies on that when you're fighting something you burn more energy." (said at 1:24:10)

Clinical and metabolic physiology literature demonstrates that active infections, systemic inflammation, and associated febrile responses increase basal and resting energy expenditure. While mild localized immune triggers (such as certain vaccines) may not always produce a detectable whole-body elevation in resting metabolic rate, fighting active systemic infections reliably elevates metabolic rate and nutrient requirements.

1:17:20Martin Picardsupportedmoderate

Visceral fat accumulation is associated with increased systemic inflammation.

"And the visceral fat is linked to increased inflammation and it's linked to a bunch of diseases, but this is just a symptom." (said at 1:17:20)

A robust body of observational and mechanistic evidence confirms that visceral adipose tissue (VAT) accumulation is directly associated with elevated markers of systemic inflammation, including C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), often independent of total body mass index (BMI).

1:20:51Steven Bartlett (host)supportedmoderate

The phrase and concept that breakfast is the most important meal of the day originated from advertising campaigns created to sell breakfast cereal and bacon.

"I was just reading the other day that it says that this idea that breakfast is the most important meal of the day came from an advertising campaign that was designed to sell cereal and bacon." (said at 1:20:51)

Historical and media analysis confirms that the modern framing of breakfast as essential—and specifically the popularization of a hearty breakfast including bacon and cereal—stemmed largely from 20th-century commercial public relations and advertising campaigns. In the 1920s, public relations pioneer Edward Bernays orchestrated a campaign for the Beech-Nut Packing Company by soliciting physician endorsements for a heavy breakfast to drive bacon sales. Subsequently, in 1944, General Foods launched an advertising campaign for Grape-Nuts cereal that popularized the explicit phrase that breakfast is the 'most important meal of the day'.

1:42:36Steven Bartlett (host)supportedlow

In a longitudinal study in Chicago examining post-mortem brains, individuals who reported a greater sense of purpose before death were found to have higher mitochondrial energy transformation capacity in the dorsolateral prefrontal cortex.

"I read that studies on brains of dead people have found that those with a greater sense of purpose have more efficient mitochondria?... In in the the dorsolateral prefrontal cortex. So, that little part of the brain that's involved in, you know, active reasoning and executive function. And the mitochondria in the people who felt more purpose had a greater energy transformation capacity." (said at 1:42:36)

A 2024 study (using data from the Rush Memory and Aging Project longitudinal cohort in Chicago) analyzed postmortem dorsolateral prefrontal cortex tissue alongside longitudinal antemortem psychosocial assessments. It demonstrated that positive psychosocial well-being, including purpose in life, was associated with greater abundance of mitochondrial oxidative phosphorylation (OxPhos) proteins (energy transformation machinery). As an observational postmortem study, causal direction cannot be established, warranting a low GRADE certainty, but the host's description accurately reflects the published research.

1:44:21Martin Picardsupportedvery low

Chronic stress and social defeat in animal models alter mitochondrial function in the brain.

"People have done studies in animals, and we've done some of those studies, where you can basically change the state of mind of a mouse by like stressing it out chronically. And then you make it feel defeated and like a really stressful life. And you ask, 'Does this change the mitochondria in the brain?' Right? Can the experience of stress change the mitochondria in the brain? 100%. That happens." (said at 1:44:21)

The speaker's statement accurately reflects published experimental research in rodent models. A 2018 systematic review of experimental animal studies on psychological stress and mitochondria found that controlled stressors, including chronic stress and social defeat paradigms, reliably induce structural and functional alterations in brain mitochondria (such as impaired respiration, elevated oxidative stress, and altered dynamics). Recent experimental studies using the chronic social defeat stress (CSDS) model in mice further demonstrate that chronic social defeat upregulates fission proteins (e.g., Drp1) and dysregulates mitochondrial proteomic pathways in brain regions such as the hippocampus and prefrontal cortex.

1:44:45Martin Picardsupportedvery low

Direct pharmacological or genetic boosting or inhibiting of brain mitochondria in animal models alters anxiety and social dominance behaviors.

"Now you can say, 'Okay, now let's change the mitochondria in the brain. You can like open up the brain, inject a little something that either boost the mitochondria or inhibit and inactivate the mitochondria, increase or decrease resistance.' And then you ask, 'Does this change how the animal appears to feel? How do animals behave in terms of anxiety or social interactions with other animals, sociality or dominance?' 100%." (said at 1:44:45)

Animal research directly supports the speaker's claim. In rodent models, direct pharmacological inhibition of mitochondrial complex I or II in the nucleus accumbens (NAc) impairs social dominance, while boosting mitochondrial function (e.g., via intra-accumbal nicotinamide infusion) prevents subordination. Furthermore, targeted genetic manipulation of mitochondrial proteins (such as mitofusin-2 / Mfn2 overexpression or knockdown in NAc neurons) directly modulates anxiety-like behavior and social rank establishment. Certainty is rated very low because the evidence is restricted to preclinical animal models.

1:46:18Martin Picardsupportedhigh

Circulating GDF15 levels are elevated in cancer, Alzheimer's disease, diabetes, hypertension, and heart disease.

"and there's this protein marker in the blood that reflects energy friction, energy resistance, right?... It's elevated in cancer, where we think there's increased energy resistance. It's elevated in Alzheimer's, where we think there's increased energy resistance in the brain. It's elevated in diabetes, where there's increased energy resistance with the insulin resistance. It's elevated in all sorts of pathologies, hypertension and the heart disease" (said at 1:46:18)

Extensive clinical and biomarker research establishes that circulating levels of growth differentiation factor 15 (GDF-15)—a cytokine induced by cellular stress, mitochondrial dysfunction, and tissue injury—are elevated across numerous chronic conditions, including cancer, neurodegenerative disorders (such as Alzheimer's disease), type 2 diabetes, hypertension, and cardiovascular disease.

1:48:35Martin Picardsupportedmoderate

Acute laboratory psychosocial mental stress induces a measurable increase in circulating blood levels of GDF15.

"And then they have to look into into the camera and they do their their defense and they know someone's looking at them. And what we saw was that this energy stress marker goes up. Just with mental stress. You're not doing exercise, you're not doing anything strenuous." (said at 1:48:35)

Controlled laboratory experimental human studies demonstrate that acute social-evaluative mental stress (such as the Trier Social Stress Test, involving speaking/defending in front of evaluators/cameras without physical exertion) induces a rapid, measurable increase in circulating levels of GDF15 in both plasma and saliva.

1:50:39Martin Picardsupportedvery low

Injecting animals with GDF15 induces sickness behavior, causing them to hunch into a ball and become inactive.

"We know that this specifically from animal studies, if you inject animals with GDF15, they hunch in a ball and they don't do anything, right? They go into this sickness behavior." (said at 1:50:39)

Preclinical animal evidence supports that pharmacological administration (injection) of growth differentiation factor 15 (GDF15) triggers a central sickness-like response mediated by its hindbrain receptor (GFRAL). Studies show that exogenous GDF15 suppresses appetite, induces malaise/nausea-like states, and causes hypolocomotion or reduced voluntary physical activity (such as running wheel activity). Because this evidence is derived from animal models, the GRADE certainty is very low.

1:51:36Martin Picardsupportedmoderate

Data from the UK Biobank with 14 years of follow-up demonstrates that high baseline GDF15 levels are associated with higher rates of mental illness, cardiovascular disease, hypertension, and all-cause mortality.

"and then you wait 14 years. This is actually a study from the UK. It's called the UK Biobank. So if you measure the protein energetic stress cytokine and you ask, 'What happens to people with high GDF15 versus people with low GDF15?' Turns out people with high GDF15 are more likely to develop mental illness... Bipolar disease, depression, schizophrenia. People with high GDF15 are more likely to develop cardiovascular disease, hypertension. People with high GDF15 are more likely to be dead." (said at 1:51:36)

Large-scale prospective analyses from the UK Biobank (with ~14 years of follow-up and over 50,000 participants with proteomic profiling) demonstrate that elevated plasma GDF-15 (growth differentiation factor 15), a biomarker reflective of cellular/mitochondrial energetic stress, is strongly associated with a broad spectrum of adverse incident health outcomes. These include psychiatric conditions (depression/anxiety and mental disorders), cardiovascular diseases, and all-cause and cause-specific mortality.

1:53:26Martin Picardsupportedlow

Circulating GDF15 levels increase progressively over the course of the day.

"what we know is there's some initial evidence that GDF15 increases throughout the day, right?" (said at 1:53:26)

The speaker accurately qualifies the claim as 'some initial evidence that GDF15 increases throughout the day.' Small human observational studies have observed modest diurnal variations in circulating GDF15 levels over 24 hours, including daytime fluctuations or evening-peaking profiles in subgroups, although overall 24-hour rhythmic variation is small compared to other metabolic hormones and evidence remains preliminary.

1:56:22Martin Picardsupportedvery low

Methylene blue donates electrons directly to the mitochondrial electron transport chain.

"What biologically methylene blue seems to be able to give electrons to the mitochondria. So, maybe there's something there that methylene blue can help relieve energy resistance in the mitochondria." (said at 1:56:22)

Biochemical and preclinical studies demonstrate that methylene blue acts as an alternative electron carrier/donor in the mitochondrial electron transport chain, accepting electrons from NADH or upstream complexes and donating them downstream directly to cytochrome c to sustain oxygen consumption and ATP production, even in the setting of electron transport chain inhibition.

1:57:58Martin Picardsupportedhigh

Urolithin A stimulates mitophagy to degrade dysfunctional mitochondria.

"Urolithin A is a a new compound that seems to stimulate the degradation of bad mitochondria... What urolithin A seems to do is to kind of accelerate this process. Right? So, it accelerates the degradation of the bad mitochondria, the mitophagy, so that the cell has to make more of the good ones." (said at 1:57:58)

Extensive preclinical research and multiple human randomized controlled trials demonstrate that urolithin A (a gut microbiome metabolite derived from dietary ellagitannins) activates mitophagy—the selective autophagic degradation and recycling of damaged or dysfunctional mitochondria—upregulating mitochondrial quality control and biogenesis pathways.

1:59:00Steven Bartlett (host)supportedmoderate

A 2022 randomized, double-blind study in JAMA Network Open in adults aged 65 to 90 showed that 4 months of urolithin A supplementation produced statistically significant improvements in muscle endurance and reductions in biomarkers of mitochondrial inefficiency.

"with one study in 2022 in the JAMA Network Open journal where they took adults aged 65 to 90 and gave one of them placebo one of the groups placebo and the other urolithin A for 4 months and at the end of that they found that the group that were given urolithin A showed statistically significant improvements in muscle endurance and a reduction in biomarkers of mitochondrial inefficiency." (said at 1:59:00)

A 2022 randomized, double-blind, placebo-controlled trial published in JAMA Network Open (PMID 35050355) evaluated 4 months of daily urolithin A supplementation (1000 mg) versus placebo in 66 adults aged 65 to 90 years. The trial found statistically significant improvements in muscle endurance (contractions until fatigue in the first dorsal interosseus and tibialis anterior) and significant reductions in plasma biomarkers of mitochondrial inefficiency and metabolic health (such as acylcarnitines, ceramides, and C-reactive protein). Although the primary endpoints (6-minute walk distance and maximal ATP production) did not reach statistical significance, the speaker's description of the study design, population, duration, and specific positive findings for muscle endurance and plasma biomarkers is accurate.

  • supports: Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Olde… (JAMA network open 2022) · cited 196x in the literature
    "This double-blind, placebo-controlled randomized clinical trial in adults aged 65 to 90 years was conducted at a medical center and a cancer research center in Seattle, Washington, from March 1, 2018, to July 30, 2020... Participants were randomized to receive daily oral supplementation with either 1000 mg urolithin A or placebo for 4 months... Urolithin A, compared with placebo, significantly improved muscle endurance (ie, increase in the number of muscle contractions until fatigue from baseline) in the FDI and TA at 2 months... Plasma levels of several acylcarnitines, ceramides, and C-reactive protein were decreased by urolithin A, compared with placebo, at 4 months" (abstract, methods and results, passage verified)
    pubmedfull study (doi)
1:59:47Martin Picardsupportedmoderate

Excessive intake of antioxidant supplements impairs normal physiological cellular signaling and adaptation.

"anti-inflammatory, you know, berries and antioxidants was a big thing like 10 20 years ago. Turned out not to be so useful. Actually impairs normal adaptation and signaling if you eat too many antioxidants." (said at 1:59:47)

The claim is supported. Controlled human trials and mechanistic reviews demonstrate that physiological levels of reactive oxygen species (ROS) serve as essential second messengers (the concept of mitohormesis). High-dose antioxidant supplementation (such as vitamins C and E) can blunt redox-sensitive cellular signaling cascades (e.g., PGC-1α expression, endogenous antioxidant enzyme induction) and attenuate specific training-induced metabolic adaptations, such as improvements in insulin sensitivity. However, broader systematic reviews note that high-dose antioxidants do not consistently impair macro-level functional outcomes like maximal oxygen uptake (VO2max) or muscle strength across all exercise protocols.

2:01:37Martin Picardsupportedmoderate

Hospitalized patients with plants in their rooms or windows with views of natural light and nature recover faster from illness and surgery.

"and there's good research showing if you put a plant in a hospital patients recover faster. There's been studies looking at like windows with natural light then you see nature if you're in a hospital for example, people recover better." (said at 2:01:37)

The speaker's claim accurately reflects published research in environmental psychology and post-operative recovery. A landmark study by Ulrich (1984, Science) found that surgical patients with window views of a natural tree setting had shorter postoperative hospital stays, took fewer moderate-to-strong analgesics, and received fewer negative nursing notes compared to matched patients with views of a brick wall. Similarly, a randomized clinical trial by Park & Mattson (2009) in 90 surgical patients demonstrated that placing indoor plants and flowers in hospital rooms reduced systolic blood pressure, pain ratings, anxiety, and fatigue during recovery.

2:02:18Steven Bartlett (host)supportedmoderate

Using a Bon Charge red light therapy face mask for 15 to 20 minutes a day boosts collagen production and improves fine lines and blemishes.

"This is a my Bon Charge face mask. I've been wearing this for some time now. They are a sponsor of the podcast. I put this on for 15, 20 minutes a day. I can sit here in the chair and wear it. Boost my collagen production, helps with fine lines, blemishes, my complexion gets better." (said at 2:02:18)

The host's statement that using a red light therapy face mask for 15 to 20 minutes improves collagen production, fine lines, and blemishes is supported by clinical trials and systematic reviews on photobiomodulation (PBM). Randomized controlled trials using LED masks (delivering red light at ~630–660 nm and near-infrared light) demonstrate significant improvements in wrinkle depth, periocular fine lines, skin texture, and collagen synthesis, with treatments typically lasting 10 to 20 minutes per session.

1:52:45Martin Picardsupportedmoderate

Higher circulating levels of GDF15 are epidemiologically associated with reduced engagement in voluntary physical activity, such as walking for pleasure and climbing stairs.

"And uh and and people with high GDF15 also, they don't like to take the stairs. They don't like to walk for pleasure. They don't like to go out to the gym. They don't like to go out with friends." (said at 1:52:45)

Epidemiological cohort analyses (including proteomic analyses of physical activity and sedentary behavior in large cohorts like the UK Biobank) and systematic reviews consistently demonstrate that higher circulating levels of GDF15 (growth differentiation factor 15) are associated with lower levels of physical activity, greater sedentary behavior, poorer physical performance, and increased frailty and functional decline.

1:56:45Martin Picardsupportedhigh

Nicotinamide adenine dinucleotide (NAD+) acts as a primary electron carrier in cellular metabolism, transferring electrons derived from nutrients to the mitochondrial electron transport chain.

"Also, it's an electron carrier. So, it take electrons from food and then gives them to the electron transport chain, so the mitochondria can flow those electrons with low resistance." (said at 1:56:45)

The statement accurately summarizes the fundamental biochemical role of the NAD+/NADH redox couple in cellular metabolism. Nicotinamide adenine dinucleotide (NAD+) functions as a primary electron carrier by accepting high-energy electrons from the catabolism of nutrients (via glycolysis, beta-oxidation, and the tricarboxylic acid cycle) to form NADH. NADH subsequently transfers these electrons directly to Complex I (NADH:ubiquinone oxidoreductase) of the mitochondrial electron transport chain, initiating electron flow that drives ATP synthesis via oxidative phosphorylation.

1:51:16Martin Picardsupportedmoderate

Elevated stress hormones mobilize glucose and lipids into the bloodstream which, if unused by tissues, deposit as ectopic visceral adipose tissue.

"when stress hormones are up, right? And you're increasing blood glucose, increasing blood lipids, if the rest of the body doesn't need it, which is what kind of happens in during a stress response like this, that fat gets lodged where it shouldn't. Called ectopic fat, and that's what belly fat is." (said at 1:51:16)

The speaker accurately describes the physiological mechanism by which stress hormones (such as catecholamines and glucocorticoids/cortisol) influence fuel metabolism and body fat distribution. Acute and chronic stress responses increase circulating glucose and free fatty acids via glycogenolysis, gluconeogenesis, and lipolysis. Glucocorticoids simultaneously upregulate lipoprotein lipase (LPL) activity and adipogenesis preferentially in visceral adipose depots (which have high glucocorticoid receptor density), promoting the re-esterification and storage of unused circulating lipids into visceral and ectopic depots (such as intra-abdominal and hepatic fat).

2:04:08Martin Picardsupportedmoderate

Infrared and red light can penetrate biological tissue, including hair and the skull, into the brain, where mitochondrial cytochrome c oxidase acts as the photoreceptor absorbing photons.

"Red light like this, especially the red, the infrared that you don't see with your eye, can penetrate tissue. It can go through your hair, through your skull, and then into your brain. And then there, it seems to do something and change metabolism... That receptor, the antenna, the cellular antenna for red light seems to be mitochondria... that is called cytochrome c oxidase." (said at 2:04:08)

The speaker accurately describes the established physical and biological mechanism of transcranial photobiomodulation (PBM). Near-infrared and red light wavelengths penetrate biological tissues (including scalp, bone/skull, and superficial brain parenchyma), where mitochondrial cytochrome c oxidase (CCO) functions as the primary chromophore/photoreceptor that absorbs these photons, altering mitochondrial respiration and cellular metabolism.

2:06:45Martin Picardsupportedhigh

Psychological stress increases blood glucose levels.

"If you get stressed out, just psychological stress will increase blood glucose." (said at 2:06:45)

Psychological stress activates the sympathetic nervous system, the hypothalamic-pituitary-adrenal (HPA) axis, and specific neural circuits (such as amygdala-to-liver signaling) that stimulate hepatic gluconeogenesis and glycogenolysis, reliably elevating blood glucose levels and causing stress hyperglycemia in both humans and animal models.

2:07:18Martin Picardsupportedlow

A study showed that shining red light on a person's back while they ingest glucose reduces the blood glucose spike and increases mitochondrial metabolism.

"It turns out if you shine a red light on the back of people as they ingest a big bunch of glucose, the spike in glucose is not as high. And what they did in that study that was interesting is they measured mitochondrial metabolism through the mouth... And what they found is that people who had red light on their back, their metabolism was actually a little higher." (said at 2:07:18)

A 2024 human crossover study by Powner & Jeffery evaluated the effect of photobiomodulation (670 nm red light applied to the upper back for 15 minutes) during an oral glucose tolerance test in healthy human participants. The study demonstrated that 670 nm red light significantly reduced postprandial blood glucose elevation over 2 hours by 27.7% and attenuated the maximum glucose spike by 7.5%, while increasing metabolic respiration/gas exchange (measured via respiratory calorimetry). The certainty is rated low due to small sample size and single-study design.

2:09:18Steven Bartlett (host)supportedlow

A 2009 study showed that low to moderate doses of light stimulate mitochondria to produce ATP and a small burst of reactive oxygen species to trigger cellular repair, whereas excessive doses generate massive reactive oxygen species that shut down mitochondrial respiration and induce apoptosis.

"They found in this one particular study I was reading about in 2009 that low to moderate doses of light perfectly stimulate the mitochondria to produce ATP and a healthy small burst of ROS, reactive oxygen species, to trigger cellular repair. However, this particular study also showed that when the dose is pushed too high, the light creates massive amounts of reactive oxidative species and this excess oxidative stress overwhelms the cells' antioxidant defenses, completely shutting down mitochondrial respiration and inducing cellular apoptosis" (said at 2:09:18)

The speaker accurately describes the findings and mechanistic model outlined in a prominent 2009 paper on photobiomodulation (Huang et al., 2009, 'Biphasic dose response in low level light therapy', PMID 20011653, and its 2011 update, PMID 22461763). The paper describes the biphasic dose-response (Arndt-Schulz curve) in low-level light therapy: low-to-moderate light doses increase mitochondrial ATP synthesis and generate low, beneficial levels of reactive oxygen species (ROS) that initiate cellular signaling and tissue repair, whereas excessive doses generate cytotoxic levels of ROS that disrupt mitochondrial respiration and trigger apoptosis. Certainty is rated low because this specific mechanistic biphasic curve is derived primarily from in vitro cell models and preclinical animal studies.

2:14:53Martin Picardsupportedmoderate

Injecting people with lactate can trigger panic attacks, and in individuals with PTSD, lactate injection can reawaken traumatic memories.

"And there's very interesting data showing that if you inject people with a signal of energetic stress, lactate, you can trigger a panic attack... And people with traumatic memories, like post-traumatic stress disorder, PTSD, the simple injection of an energetic stress signal of lactate in the blood can reawaken traumatic memories." (said at 2:14:53)

Intravenous sodium lactate infusion is an established experimental panic provocation challenge. Extensive clinical data, confirmed in meta-analyses, demonstrate that sodium lactate triggers acute panic attacks (especially in vulnerable individuals). Furthermore, clinical challenge studies in patients with post-traumatic stress disorder (PTSD) have shown that sodium lactate infusion reliably induces flashbacks and intrusive traumatic memories.

2:15:55Martin Picardsupportedmoderate

Lactate and GDF15 levels tend to be elevated in individuals with mental illness.

"And then lactate tends to be elevated in people with mental illness. And this marker GDF15 also is elevated in mental illness." (said at 2:15:55)

The claim is supported by systematic reviews and meta-analyses. Growth differentiation factor 15 (GDF-15), a biomarker of cellular stress and mitochondrial dysfunction, has been shown in meta-analyses and large prospective cohorts to be significantly elevated in individuals with depression and anxiety. For lactate, systematic reviews and meta-analyses demonstrate elevated levels in the central nervous system (brain tissue via magnetic resonance spectroscopy and cerebrospinal fluid) across psychiatric disorders such as schizophrenia and bipolar disorder, although peripheral (blood) lactate elevations are less consistently observed.

2:20:29Martin Picardsupportedlow

An estimated 3 to 5 million people in the US, 2 to 3 million in the UK, and 20 to 24 million worldwide have either ME/CFS or long COVID.

"In the US, there is an estimated like 3 to 5 million people who have either myalgic encephalomyelitis, chronic fatigue syndrome, ME/CFS, or, you know, long COVID version of this. Uh, in the UK, it's somewhere between like 2 and 3 million, I think. And then worldwide, there's 20 to 24 million people have these syndromes, right?" (said at 2:20:29)

Epidemiological studies and consensus reports estimate that ME/CFS affects approximately 1.5 to 3.4 million individuals in the US (with post-COVID increases expanding estimates into the 3 to 5 million range), approximately 250,000 to over 2 million individuals in the UK when combined with ongoing Long COVID (ONS and UK health surveys), and between 17 and 24 million individuals globally prior to/including post-viral syndromes. Because these conditions rely on clinical diagnostic criteria and survey/claims data rather than definitive diagnostic biomarkers, population estimates carry low certainty due to diagnostic variability and underdiagnosis.

2:22:31Martin Picardsupportedmoderate

A recent study analyzing muscle biopsies from the quadriceps of chronic fatigue syndrome patients found a significantly lower mitochondrial energy transformation capacity.

"The best study on on mitochondria and uh chronic fatigue syndrome was published last year or the year before, and it showed that there is a deficiency in energy transformation in the mitochondria of the muscle. They took muscle biopsies, little piece of muscle from the from the quad, from the the thigh, and then they looked at how well can the mitochondria in the muscle of people with chronic fatigue syndrome flow energy. And what they found is the capacity is much lower." (said at 2:22:31)

Recent published studies evaluating skeletal muscle biopsies (specifically from the vastus lateralis / quadriceps) in patients with ME/CFS and post-viral fatigue syndromes demonstrate significant mitochondrial structural abnormalities, disrupted respiratory supercomplex formation, reduced oxidative phosphorylation / respiratory capacity, and bioenergetic deficiency.

0:02:04Martin Picardsupportedhigh

Cytochrome c oxidase in the mitochondrial electron transport chain is the enzyme complex where electrons and oxygen combine to produce metabolic water.

"So, there's something in the mitochondria where the electrons flow and then boom, they meet with oxygen to become metabolic water. Uh that is called cytochrome c oxidase." (said at 0:02:04)

Cytochrome c oxidase (Complex IV) is the terminal enzyme of the mitochondrial electron transport chain. It catalyzes the transfer of electrons from reduced cytochrome c to molecular oxygen, reducing oxygen (O2) and four protons to produce metabolic water (H2O), coupled with proton pumping across the inner mitochondrial membrane.

0:15:55Martin Picardsupportedmoderate

Researchers at McLean Hospital and Harvard have published data directly measuring bioenergetic impairment and energy resistance in the human brain in mental illnesses.

"And there's data directly measuring energy resistance in the brain from a group at McLean and Harvard." (said at 0:15:55)

Researchers at McLean Hospital and Harvard Medical School (notably Dost Öngür, Fei Du, and colleagues) have extensively published in vivo human brain imaging studies using phosphorus magnetic resonance spectroscopy (31P-MRS) to directly measure cerebral bioenergetics in psychiatric conditions such as schizophrenia and bipolar disorder. These studies demonstrate significant impairments in brain energy metabolism, including reduced creatine kinase reaction rates/flux, altered high-energy phosphate ratios, and redox (NAD+/NADH) imbalance. The phrase 'energy resistance' is a conceptual framing used in metabolic psychiatry to describe these demonstrated bioenergetic deficits and diminished compensatory energy production capacities.

2:36:16Martin Picardsupportedmoderate

Miscarriage occurs in approximately 20 million people worldwide each year.

"It happens to about 20 million people a year." (said at 2:36:16)

A comprehensive systematic review and global epidemiological analysis published in The Lancet Series on Miscarriage (Quenby et al., 2021) estimated that approximately 23 million miscarriages occur worldwide each year (accounting for approximately 15.3% of recognized pregnancies, or 44 losses per minute). The speaker's figure of 'about 20 million people a year' accurately reflects this established global estimate.

1 No source found (not proven false)
0:01:04Martin Picardunverifiedvery low

There are approximately 5,000 trillion mitochondria in the human body.

"And there's about 5,000 trillion mitochondria in your body." (said at 0:01:04)

No peer-reviewed biomedical publications indexing an exact figure of '5,000 trillion' (or 5 quadrillion) mitochondria in the human body were identified in PubMed. While rough back-of-the-envelope calculations multiplying the number of nucleated cells in the human body (~5-10 trillion, excluding anucleated erythrocytes) by typical mitochondrial content per cell (hundreds to thousands) yield numbers in the low quadrillions (thousands of trillions), this specific estimate has not been formally quantified or established in the indexed scientific literature.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.